JOURNAL OF CLINICAL ONCOLOGY

Rivista

Codice:

E091050

ISSN:

0732-183X

Dati Generali

Pubblicazioni (250)

2-(F-18)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: A prospective study

Articolo

A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)

Articolo

A call for clinical trials: Lipophilic statins may prove effective in treatment and prevention of particular breast cancer subtypes - Reply

Articolo

A circulating miRNA signature to implement diagnostic imaging analysis in young early-stage breast cancer patients

Abstract

A monocentric retrospective analysis of TILs and AR as hints for prognosis definition in TNBC

Abstract

A multicentre phase 2 study of carboplatin (C) plus pegylated liposomal doxorubicin (PLO) as first-line chemotherapy for patients (pts) with advanced or recurrent endometrial carcinoma (AEC): The END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer) Group

Articolo

A phase II study of regorafenib in patients with thymic epithelial tumours previously treated with chemotherapy

Articolo

A randomized phase II trial of two different four-drug combinations in advanced pancreatic adenocarcinoma: Cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel

Abstract

A. Micrometastasis in sentinel (SLN) and non sentinel lymph nodes of breast cancer: an update including clinico-pathologic impact and survaival

Poster

ADJUVANT CYVADIC CHEMOTHERAPY FOR ADULT SOFT-TISSUE SARCOMA-REDUCED LOCAL RECURRENCE BUT NO IMPROVEMENT IN SURVIVAL - A STUDY OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER SOFT-TISSUE AND BONE SARCOMA GROUP

Articolo

Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial

Articolo

Addition of temozolomide to radiotherapy for treatment of newly diagnosed anaplastic gliomas

Abstract

Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial

Articolo

Advanced colorectal liver metastases and surgery after preoperative chemotherapy : is response-based selection enough?

Articolo

Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: Ten-year results

Articolo

Association between salivary cytokine levels and chemoradiotherapy-induced toxicities in head and neck cancer patients

Articolo

Association of immune contexture, age, and tumor stage in peripheral neuroblastic tumors (PNT)

Abstract

Atypical lipomatous tumors/well-differentiated liposarcoma of the extremity: Analysis of a series of 65 patients treated in a single institution

Abstract

BEST OF: A phase III study assessing the best of radiotherapy (Intensity Modulated RadioTherapy, IMRT) compared to the best of surgery (Trans-Oral Surgery, TOS) in patients with T1-T2, N0 oropharyngeal squamous cell carcinoma (OPSCC).

Articolo

Baseline and early change of neutrophil to lymphocyte ratio (bNLR and ΔNLR) as prognostic factors in metastatic renal cell carcinoma (mRCC) treated with Nivolumab: Final results of the Meet-URO 15 (I-BIO-REC) study

Abstract

Baseline and early change of systemic inflammation index (bSII and ΔSII) as prognostic factors in metastatic renal cell carcinoma (mRCC) patients treated with Nivolumab: Final results of the Meet-URO 15 (I-BIO-REC) study

Poster

Baseline tumor size as prognostic index in patients with cancer receiving experimental targeted agents

Abstract

Bendamustine in combination with gemcitabine and vinorelbine is an effective regimen as induction chemotherapy before autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma : Final results of a multicenter phase II study

Articolo

Beyond semantic: the need to better categorie patients with cancer.

Articolo

Biological and clinical features of early triple-negative invasive lobular carcinomas of the breast

Articolo

Bone Mineral Density and FRAX Score May Not Predict Fracture Risk in Patients With Cancer Undergoing Hormone Deprivation Therapies

Articolo

Carbonic anhydrase IX expression in clear cell renal cell carcinoma and normal tissues: Experiences from (radio) immunotherapy

Articolo

Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III Trial

Articolo

Caregiver training for a therapeutic alliance in palliative home care.

Abstract

Case 2. Mediastinal liposarcoma in a patient with previous testicular cancer

Articolo

Celecoxib plus cartioplatin in heavily pre-treated patients with recurrent ovarian carcinoma: Preliminary results of a Phase II study

Articolo

Changes in shedding of soluble tumor necrosis factor receptors (sR1/R2) and in dynamic MRI as early predictors of outcome with NGR-hTNF

Abstract

Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic Syndromes

Articolo

Characterization of tumor microenvironment in extraskeletal myxoid chondrosarcoma (EMC)

Abstract

Chemoradiotherapy in Gastric Cancer: A Door Ajar

Articolo

Chlamydia psittaci (Cp)-eradicating therapy with doxycycline is an active treatment against ocular adnexa MALT lymphoma (OAML): Final results of a multicentre prospective trial.

Abstract

Chlamydophila Psittaci Eradication With Doxycycline As First-Line Targeted Therapy for Ocular Adnexae Lymphoma: Final Results of an International Phase II Trial

Articolo

Circulating pretreatment Epstein Barr Virus DNA quantification as a prognostic factor in nasopharyngeal cancer patients in a non endemic area

Articolo

Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes

Articolo

Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status

Articolo

Clinical Effects of Driver Somatic mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With allogeneic Hematopoietic Stem-Cell Transplantation

Articolo

Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes

Articolo

Clinical and prognostic implications of sarcopenia in patients affected by locally advanced NSCLC.

Abstract

Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndrome

Articolo

Combination chemotherapy followed by chemoradiation for stage III pancreatic adenocarcinoma (PA)

Abstract

Commonly used imaging techniques for diagnosis and staging

Articolo

Complications of therapy and a diagnostic dilemma case of - CASE 2. Cutaneous toxicity induced by cetuximab

Articolo

Comprehensive geriatric evaluation in elderly patients with lymphoma: Feasibility of a patient-tailored treatment plan

Articolo

Concerns About the Risk of Myeloid Malignancies After Radioiodine Therapy in Thyroid Cancer

Articolo

DIAGNOSING INFECTION IN FEBRILE GRANULOCYTOPENIC PATIENTS WITH INDIUM-111-LABELED HUMAN IMMUNOGLOBULIN-G

Articolo

DOXORUBICIN VERSUS CYVADIC VERSUS DOXORUBICIN PLUS IFOSFAMIDE IN FIRST-LINE TREATMENT OF ADVANCED SOFT-TISSUE SARCOMAS - A RANDOMIZED STUDY OF THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER SOFT-TISSUE AND BONE SARCOMA GROUP

Articolo

Definitive results of a phase II trial of cisplatin epirubicin, continuous-infusion fluorouracil, and gemcitabine in stage IV pancreatic adenocarcinoma

Articolo

Detecting characteristics of nodal invasion in advanced squamocellular oral cavity cancer through a gene expression profile on primary tumor

Articolo

Developing an adolescent and young adult (AYA) cancer program in an Italian adult high-volume cancer center.

Abstract

Differential impact of cisplatin dose intensity on human papillomavirus (HPV)-related (+) and HPV-unrelated (-) locoregionally advanced head and neck squamous cell carcinoma (LAHNSCC)

Articolo

Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi

Articolo

Double-Blind, Placebo-Controlled, Randomized Phase III Trial Evaluating Pertuzumab Combined With Chemotherapy for Low Tumor Human Epidermal Growth Factor Receptor 3 mRNA-Expressing Platinum-Resistant Ovarian Cancer (PENELOPE)

Articolo

Drop-out between the two liver resections of two-stage hepatectomy for multiple bilobar colorectal metastases: Patient selection or loss of chance?

Abstract

Dynamic changes of neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lactate dehydrogenase (LDH) during treatment with immune checkpoint inhibitors (ICIs) in non small cell lung cancer (NSCLC)

Abstract

Early metabolic response as predictor for treatment outcome of pazopanib in patients with metastatic soft tissue sarcomas (the PREDICT study).

Abstract

Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [F-18]fluorodeoxyglucose

Articolo

Effect of increased MET gene copy number on survival of surgically resected non-small cell lung cancer (NSCLC) patients

Articolo

Effect of intratumoral CD3+and NKp46+cells on tumor progression in resected colorectal liver metastases treated with neoadjuvant chemotherapy.

Abstract

Effectiveness of trastuzumab in first-line HER2+metastatic breast cancer after failure in adjuvant setting: A controlled cohort study

Abstract

Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study

Articolo

Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: A prospective study

Articolo

Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

Articolo

Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: A double-blind, placebo-controlled, randomized study in cancer patients

Articolo

Epidermal growth factor receptor gene copy number in esophageal cancer and outcome prediction to gefitinib : does intratumoral heterogeneity matter?

Articolo

Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome.

Articolo

Exemestane Plus Ovarian Function Suppression Is the Best Adjuvant Treatment of Premenopausal Women With Endocrine-Responsive Breast Cancer at Higher Risk of Relapse and With HER2-Negative Tumors

Articolo

Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance

Articolo

F-18-FDG-PET (PET) and contrast-enhanced CT-scan (CT) in the evaluation of liver metastases from colorectal cancer after chemotherapy

Abstract

FOLFOX/CAPOX in stage II–III colon cancer: efficacy results of the Italian Three Or Six Colon Adjuvant trial (TOSCA)

Articolo

Familial chronic myeloproliferative disorders: clinical phenotype and evidence of disease anticipation

Articolo

Fatal Infusion Reaction to Cetuximab: The Need for Predictive Risk Factors and Safer Patient Selection

Articolo

Feasibility of preoperative chemotherapy with or without radiation therapy in localized soft tissue sarcomas of limbs and superficial trunk in the Italian sarcoma group/grupo español de investigación en sarcomas randomized clinical trial: Three versus five cycles of full-dose epirubicin plus ifosfamide

Articolo

Final results from ARQ 197-114: A phase 1b safety trial evaluating ARQ 197 in cirrhotic patients (pts) with hepatocellular carcinoma (HCC)

Abstract

First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826

Articolo

Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: Update of study BIG 1-98

Articolo

Folate in head and neck squamous cell cancer chemoprevention: Purposely left out?

Articolo

Gemcitabine (GEM) and liposomal doxorubicin (PLO) in recurrent/metastatic breast carcinoma: A phase II study

Articolo

Gemcitabine as a single agent in the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma

Articolo

Gemcitabine in the treatment of refractory Hodgkins's disease: Results of a multicenter phase II study

Articolo

Gene modules and response to neoadjuvant chemotherapy in breast cancer subtypes: a pooled analysis

Articolo

Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell–Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial

Articolo

Health and economic outcomes of two different follow up strategies in effectively cured advanced head and neck cancer patients

Articolo

Health care-associated infections (HAIs) in head and neck carcinoma (HNC) patients treated with chemotherapy (CT) and/or radiotherapy (RT)

Articolo

High-dimensional single cell-based immune profiling of the tumor immune microenvironment in prostate cancer

Abstract

High-dose chemotherapy in poor-prognosis adult small round-cell tumors: Clinical and molecular results from a prospective study

Articolo

High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion : an outpatient preparative regimen for autologous hematopoietic cell transplantation

Articolo

High-grade gliomas (HGGs) and immunotherapeutic early-phase clinical trials (ieCTs): A single-center experience

Abstract

High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma

Articolo

How Many Therapeutic Options Are There for Recurrent or Metastatic Salivary Duct Carcinoma?

Articolo

Human Papillomavirus Antibodies and Future Risk of Anogenital Cancer: A Nested Case-Control Study in the European Prospective Investigation Into Cancer and Nutrition Study

Articolo

Identification of a gene expression profile associated with progression-free survival (PFS) in relapsed or metastatic (RM) head and neck squamous cell cancer (HNSCC) patients (pts) treated with first-line cetuximab and platinum therapy

Articolo

Identification of an actionable mutation of KIT in extraskeletal myxoid chondrosarcoma (EMC)

Abstract

Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes

Articolo

Immune checkpoint inhibitor in high-risk oral potentially malignant disorders (IMPEDE study): An interim analysis on safety

Abstract

Impact of pathological stratification of advanced well differentiated/dedifferentiated (WD/DD) liposarcoma (LPS) on the response to trabectedin (T)

Abstract

Improved selection of patients for hepatic surgery of colorectal liver metastases with FDG-PET: A randomized study

Abstract

In Reply

Articolo

Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non-Small-Cell Lung Cancer Patients

Articolo

Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in NRAS-Mutant Melanoma: Results From the Expansion Arm of a Phase Ib, Open-Label Study

Articolo

Interim positron emission tomography response-adapted therapy in advanced-stage Hodgkin Lymphoma: final results of the phase II part of the HD0801 study

Articolo

Is restoring platinum sensitivity the best goal for cetuximab in recurrent/metastatic nasopharyngeal cancer? [15]

Articolo

Juxtaglomerular cell tumor: Multicentric synchronous disease associated with paraneoplastic syndrome

Articolo

Lack of efficacy of two consecutive treatments of radioimmunotherapy with I-131-cG250 in patients with metastasized clear cell renal cell carcinoma

Articolo

Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775

Articolo

Lipophilic statins merit additional study for breast cancer chemoprevention - Reply

Articolo

Long-term benefit from trabectedin (T) in myxoid liposarcoma (MLS) patients

Articolo

Long-term follow-up of patients (pts) with relapsed or refractory (r/r) follicular lymphoma (FL) treated with copanlisib

Abstract

Long-term results of autologous hematopoietic stem-cell transplantation after high-dose 90Y-ibritumomab tiuxetan for patients with poor-risk non-Hodgkin lymphoma not eligible for high-dose BEAM

Articolo

Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy.

Articolo

Major histocompatibility complex class II and programmed death ligand 1 expression predict outcome after programmed death 1 blockade in classic Hodgkin Lymphoma

Articolo

Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer

Articolo

Meta-analysis: Risk of congestive heart failure (CHF) in selected targeted agents

Articolo

Microinvasive breast cancer (Tmic): A descriptive mono-institutional report

Abstract

Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: Can it be safely associated with fluorouracil-based chemotherapy?

Articolo

Multidisciplinary approach to patients with recurrent colorectal liver metastases.

Abstract

Multiomics approach for patient stratification and novel target identification in metastatic clear cell renal carcinoma (MeetUro 31): Preliminary analysis of radiomics features—A Meet-URO and AIRC study (NCT05782400)

Articolo

NGR-hTNF in previously treated patients with malignant pleural mesothelioma (MPM)

Abstract

Negative Hyperselection of Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance Therapy

Articolo

Nivolumab (NIVO) plus ipilimumab (IPI) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040.

Articolo

Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial

Articolo

Nivolumab for relapsed/refractory classic Hodgkin lymphoma after failure of autologous hematopoietic cell transplantation: extended follow-up of the multicohort single-arm phase II CheckMate 205 trial

Articolo

Non conventional suboptimal doses of gemcitabine (G) at fixed dose rate (FOR) infusion, combined with cisplatin (C), in patients with advanced non-small cell lung cancer (NSCLC)

Articolo

Nurses and health care assistants: Evaluation of attitude towards the care of patients who are terminally ill with cancer.

Abstract

Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results

Articolo

Oncofid-P-B for the treatment of BCG unresponsive carcinoma in situ (CIS) of bladder: Results of European multicenter phase I study at the end of 12- consecutive weeks intensive course

Abstract

Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD

Articolo

Outcome prediction to erlotinib in gastroesophageal adenocarcinomas : can we improve epidermal growth factor receptor and phospho-AKT testing?

Articolo

PD-1 blockade in anaplastic thyroid carcinoma

Articolo

PERSISTENCE OF EFFICACY OF 3 ANTIEMETIC REGIMENS AND PROGNOSTIC FACTORS IN PATIENTS UNDERGOING MODERATELY EMETOGENIC CHEMOTHERAPY

Articolo

PET/CT with 89Zr-trastuzumab and 18F-FDG to individualize treatment with trastuzumab emtansine (T-DM1) in metastatic HER2-positive breast cancer (mBC).

Abstract

Palifermin in Prevention of Head and Neck Cancer Radiation-Induced Mucositis: Not Yet a Definitive Word on Safety and Efficacy Profile

Articolo

Pattern of growth of retroperitoneal sarcoma: Do they push or infiltrate adjacent organs? Analysis of a single institution series

Abstract

Patterns of tumor response to trabectedin (ET743) in myxoid liposarcomas

Articolo

Pembrolizumab in MMR-proficient metastatic colorectal cancer pharmacologically primed to trigger dynamic hypermutation status: The ARETHUSA trial.

Abstract

Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy for Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient Tumors

Articolo

Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor–2 Rearrangement: Results From the Phase III FIGHT-302 Trial

Articolo

Pharmacodynamic (PD) evaluation of soluble proteins from a phase I trial of lapatinib (L) in combination with sorafenib (S)

Abstract

Phase 1 study of PF-03446962 (anti-ALK-1 mAb) in hepatocellular carcinoma (HCC): Correlation of tumor and serum biomarker data with disease control

Abstract

Phase I and pharmacodynamic study of high-dose NGR-hTNF in patients with solid tumors

Abstract

Phase I safety, pharmacokinetic (PK), and pharmacodynamic (PD) trial of NGR-hTNF given at high doses in patients with refractory solid tumors

Abstract

Phase I study of NGR-hTNF administered at high doses in refractory patients with solid tumors

Abstract

Phase I study of PF-03446962 (anti-ALK-1 mAb) in hepatocellular carcinoma (HCC)

Abstract

Phase I trial of tivantinib in combination with carboplatin and pemetrexed as first-line treatment in patients with advanced nonsquamous non small cell lung cancer or malignant pleural mesothelioma

Abstract

Phase I, pharmacokinetic (PK), pharmacodynamic (PD) study of lapatinib (L) in combination with sorafenib (S) in patients with advanced refractory solid tumors

Abstract

Phase I, pharmacokinetics, pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors

Poster

Phase II Study of Asparagine-Glycine-Arginine-Human Tumor Necrosis Factor alpha, a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesothelioma

Articolo

Phase II exploratory study of brostallicin in patients with ovarian cancer resistant/refractory to platinum-based chemotherapy

Articolo

Phase II randomized trial on dose-escalated sorafenib (S) versus best supportive care (BSC) in patients with advanced hepatocellular carcinoma (HCC) with disease progression on prior S treatment.

Abstract

Phase II study of Lutetium-177-labeled anti-Carbonic Anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma.

Abstract

Phase II study of avelumab plus intermittent axitinib in previously untreated patients with metastatic renal cell carcinoma (Tide-A study)

Poster

Phase II study of everolimus in patients with thymoma and thymic carcinoma previously treated with cisplatin-based chemotherapy

Articolo

Phase II study of oxaliplatin (OXA) and docetaxel (DTX) in recurrent ovarian cancer

Articolo

Phase II study of oxaliplatin (OXA) and docetaxel (DTX) in recurrent platinum-sensitive ovarian cancer

Articolo

Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma

Articolo

Phase II study of sorafenib in patients with advanced hepatocellular carcinoma

Articolo

Phase II study on pemetrexed in advanced and/or recurrent cervical cancer patients: a MITO study

Articolo

Phase II study: Docetaxel-cisplatin and pro drug tegafur (TPF) as neoadjuvant treatment in advanced patients with head and neck cancer (HNC): Results and correlation between tandem magnesium/creatinine and toxicity

Abstract

Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of malignant pleural mesothelioma (MPM)

Articolo

Phase III Trial Comparing Vinflunine With Docetaxel in Second-Line Advanced Non-Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy

Articolo

Phase III multinational, randomized, double-blind, placebo-controlled study of Tivantinib (ARQ 197) plus Erlotinib vs Erlotinib alone in previously treated patients with locally advanced or metastatic nonsquamous non-small-cell lung cancer.

Articolo

Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy

Articolo

Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer

Articolo

Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma

Articolo

Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Gemcitabine/Cisplatin Alone or With Sorafenib for the First-Line Treatment of Advanced, Nonsquamous Non-Small-Cell Lung Cancer.

Articolo

Phase IV trial of dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma.

Abstract

Phase Lib trial of tivantinib in combination with carboplatin and pernetrexed as first-line treatment in patients (pts) with advanced nonsquamous NSCLC or malignant pleural mesotheliorna (MPM)

Abstract

Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma

Articolo

Population-Based External Validation of a Competing-Risks Nomogram for Patients With Localized Renal Cell Carcinoma

Articolo

Positive positron emission tomography scan in sarcoidosis and two challenging cases of metastatic cancer

Articolo

Postoperative Chemoradiotherapy or Surgery Alone for Gastric Cancer: The Plausibility of the Question and Pertinence of the Answer

Articolo

Postoperative nomogram for predicting survival after resection for intrahepatic cholangiocarcinoma

Abstract

Predicting Functional Recovery and Quality of Life in Older Patients Undergoing Colorectal Cancer Surgery: Real-World Data From the International GOSAFE Study

Articolo

Prediction of TP53 status for primary cisplatin, fluorouracil, and leucovorin chemotherapy in ethmoid sinus intestinal-type adenocarcinoma

Articolo

Predictive role of peritumoral CD3+infiltration and neutrophil to lymphocyte ratio on overall survial in pateints affected by colorectal liver metastases treated with chemotherapy and surgery.

Abstract

Prevention and Management of Osteoradionecrosis in Patients With Head and Neck Cancer Treated With Radiation Therapy: ISOO-MASCC-ASCO Guideline

Articolo

Primary ipilimumab/nivolumab followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome

Articolo

Primary resistances to EGFR inhibitors (EGFRi) in HPV-positive and -negative oropharyngeal squamous cell carcinoma (OSCC)

Articolo

Prognostic and Predictive Roles of Thymidylate Synthase Expression in Lung Cancer: The Debate Is Still Open

Abstract

Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole

Articolo

Prognostic and predictive value of vessels encapsulating tumor clusters (VETC) in renal cell carcinoma (RCC)

Abstract

Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making

Articolo

Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: An analysis of 2,185 patients treated with anthracycline-containing first-line regimens - A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study

Articolo

Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy

Articolo

Prognostic role of MRP1 in localized high-risk soft tissue sarcoma (STS): Translational research associated to randomized phase III trial (ISG-STS 1001)

Abstract

Prognostic role of PI3KCA and TP53 in HPV-negative oropharyngeal cancers (OPCs)

Articolo

Prognostic role of nitrotyrosines in surgically resected non-small cell lung cancer (NSCLC)

Abstract

Prognostic value of Ki67LI in HER2-negative luminal (HNL) early breast cancer (EBC): A 14-year single institution experience with long follow-up

Articolo

Prognostic value of different standard uptake values (SUV) of primary tumor measured with FDG-PET in resectable non-small cell lung cancer.

Articolo

Prognostic value of microscopic evaluation of organ infiltration and visceral resection margins (VRM) in patients with retroperitoneal sarcomas (RPS)

Abstract

Prognostic value of vessels encapsulating tumor clusters (VETC) in sarcoma

Abstract

Prospective Comparison of [F-18] Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography in Patients With Melanoma With Palpable Lymph Node Metastases: Diagnostic Accuracy and Impact on Treatment

Articolo

Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study

Articolo

Randomized phase II study on gemcitabine with or without ramucirumab as second-line treatment for advanced malignant pleural mesothelioma (MPM): Results of Italian Rames Study

Poster

Randomized phase III study of matrix metalloproteinase inhibitor BMS-275291 in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18

Articolo

Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

Articolo

Regaining a satisfactory quality of life and predicting functional decline after major cancer surgery in older adults: The Geriatric Oncology Surgical Assessment and Functional rEcovery after Surgery (GOSAFE) study

Articolo

Reply to P.-H. Luo et al

Articolo

Reply to Y. Pointreau et al

Articolo

Resected pancreatic cancer: A proposal for a prognostic score.

Abstract

Response to Sunitinib in an Adult Patient With Rhabdoid Renal Cell Carcinoma

Articolo

Retreatment with pemetrexed-based chemotherapy (PBC) in patients with malignant pleural mesothelioma (MPM): An observational study

Abstract

Retrospective analysis of an alternative immuno-score in clinical management of patients with pT2 urothelial carcinoma

Abstract

Role of SBRT with VMAT technique and FFF beams for lymph-node metastases in oligometastatic patients from genitourinary malignancies

Abstract

Routinely Updating Patients With Cancer About Variant of Uncertain Significance Reclassifications: A Premature Responsibility for Community Oncologists

Articolo

SEARCH: A phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with advanced hepatocellular carcinoma.

Articolo

Safety and activity of Combined AVElumab with Axitinib in unresectable or metastatic Thymomas B3 and Thymic carcinomas: The CAVEATT study

Abstract

Safety and efficacy of MET inhibitor tivantinib (ARQ 197) combined with sorafenib in patients (pts) with hepatocellular carcinoma (HCC) from a phase I study

Abstract

Screening of BRCA2 mutated men for detection of prostate cancer: Preliminary results from a national high volume cancer center

Abstract

Second acute leukemia and other malignancies following treatment for Hodgkin's disease.

Articolo

Sex Differences in Efficacy and Toxicity of Systemic Cancer Treatments: Role of the Microbiome

Articolo

Should cytoreductive treatment be performed before transplantation in patients with high-risk myelodysplastic syndrome?

Articolo

Single-Agent Divarasib in Patients With KRAS G12C-Positive Non-Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I Study

Articolo

Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial

Articolo

Sorafenib in hepatitis C-virus negative patients with hepatocellular carcinoma: don’t throw the baby out with the bathwater

Articolo

Sorafenib in recurrent and/or metastatic salivary gland carcinomas (RMSGCs): An investigator-initiated phase II trial (NCT01703455)

Articolo

Statins and Reduced Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection: Further Evidence Is Warranted

Articolo

Statins and breast cancer prevention: time for randomized controlled trials - Reply

Articolo

Statins and cancer risk: A literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials

Articolo

Statins and the risk of colorectal cancer: A meta-analysis of 18 studies involving more than 1.5 million patients

Articolo

Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO)

Articolo

Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer

Articolo

Surveillance Policy for Stage IA Malignant Ovarian Germ Cell Tumors in Children and Young Adults

Articolo

TP53 Mutations and Pathologic Complete Response to Neoadjuvant Cisplatin and Fluorouracil Chemotherapy in Resected Oral Cavity Squamous Cell Carcinoma

Articolo

TPF induction chemotherapy (CT) followed by concomitant cisplatin/radiotherapy (cCTRT) in locally advanced nasopharyngeal cancer (LANPC)

Articolo

Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250

Articolo

Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

Articolo

The behavior of colorectal liver metastases in the time frame between the end of preoperative chemotherapy and liver resection: A new selection criterion for technically resectable patients

Contributo in Atti di convegno

The effect of bevacizumab on targeting of anti-epidermal growth factor receptor and anti-insulin-like growth factor 1 receptor antibodies.

Abstract

The neural phenotype in invasive urothelial carcinoma patients: Alternative score detection and prognostic implication

Abstract

Therapeutic relevance of CD34+ cell dose in blood cell transplantation for cancer therapy

Articolo

Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes

Articolo

Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study

Articolo

Trabectedin and indole-3-carbinol combination in heavily pretreated metastatic breast cancer: Results of a pilot clinical study

Articolo

Trabectedin for women with ovarian carcinoma after treatment with platinum and taxanes fails

Articolo

Treatment of Recurrent Endometrial Carcinoma: Progress Toward a More Personalized Approach

Articolo

Treatment-associated mortality in head and neck cancer receiving chemotherapy and radiation: Meta-analysis of published trials

Articolo

Tumor hypoxia as a mechanism of resistance to bevacizumab in a murine model

Contributo in Atti di convegno

Tyrosine kinase inhibitors and QTc intervals: A class effect

Abstract

Uncommon manifestations of common malignancies - Case 1. Soft-tissue metastases from malignant pleural mesothelioma

Articolo

Understanding Protective Mechanisms of an Oral Probiotic in Reducing Radiation-Induced Oral Mucositis

Articolo

Upregulation of RAS pathway to predict the risk of distant metastases in HPV plus oropharynx cancer

Articolo

Use of statins and breast cancer: A meta-analysis of seven randomized clinical trials and nine observational studies

Articolo

Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: A prospective study

Articolo

Vasectomy and Prostate Cancer Risk in the European Prospective Investigation Into Cancer and Nutrition (EPIC)

Articolo

wALT trial (Phase I-II): weekly non-pegylated liposomal anthracycline and taxane combination in first line breast cancer chemotherapy

Poster

No Results Found